相关实验视频

Updated: May 15, 2025

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Published on: April 27, 2019

心脏移植患者移植后淋巴增殖性疾病的风险预测

Nandini Nair¹, Dongping Du², Henry Johnston²

¹From the Division of Cardiology, Department of Medicine, Heart and Vascular Institute, Penn State Health/PSUCOM, Hershey, Pennsylvania.

ASAIO journal (American Society for Artificial Internal Organs : 1992)

|April 8, 2025

概括

这项研究确定了心脏移植受体中移植后淋巴增殖性疾病 (PTLD) 的风险因素. 一个预测模型发现环素和爱斯坦-巴尔病毒 (EBV) IgG阳性增加了PTLD风险.

科学领域:

心脏病学心脏病学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

移植后淋巴增殖性疾病 (PTLD) 是心脏移植接受者的重大恶性瘤.
在这个人群中,PTLD占新发癌症的10%左右.

研究的目的:

在成年心脏移植患者中识别PTLD的风险因素.
使用移植受体科学注册 (SRTR) 数据库开发PTLD风险预测模型.

主要方法:

在55150名成年心脏移植患者 (1987-2021) 的数据上使用了拉索逻辑回归.
数据分割用于模型开发,内部验证和外部验证模拟.
使用 χ 2 /威尔科克森测试 (p < 0.05) 确定了重要的变量.

主要成果:

环素,阳性捐赠者爱斯坦-巴尔病毒 (EBV) IgG,OKT3诱导和捐赠者HLA-B38抗原与3年和5年的更高PTLD风险有关.
与其他族群相比,非洲裔美国接受者患PTLD的风险较低.
在测试和验证队列中开发了一种具有良好的区分能力 (c-统计值>0.7) 的拉索回归模型.

结论:

开发的拉索回归模型有效预测心脏移植接受者的PTLD风险.
确定了关键的风险因素,包括免疫抑制和EBV状态.
强调需要先进的建模和人工智能来捕捉PTLD预测中的患者多样性.

关键词:

这是一个 PTLD.心脏移植心脏移植的心脏移植机器学习是机器学习.回归模型是一种回归模型.有关风险因素的风险因素.

更多相关视频

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...